Anticancer agents targeted against cyclin-dependent kinase 2 (CDK2): Structure-based design of irreversible and reversible inhibitors

Honorine Lebraud

Bernard Golding

Elisa Meschini

Céline Cano

Elizabeth Anscombe

Lan Wang

Jane Endicott

Martin Noble

David Newell

Roger Griffin

0 views
0 downloads